Bonesupport Holding AB
OTC:BOEUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Bonesupport Holding AB (BOEUF) under the Base Case is 49.034 USD per share.
Compared with the current market price of 31.865 USD, the stock appears
Undervalued by 35% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Bonesupport Holding AB Does
Bonesupport Holding AB makes injectable bone graft substitutes that surgeons use to fill bone voids and help damaged bone heal. Its main products are sold under the CERAMENT name and are used in orthopedic procedures such as trauma, bone infection, foot and ankle surgery, and some spine cases. The company’s customers are hospitals, surgeons, and healthcare systems that buy these products through direct sales or distributors.
- Headquarters
- Sweden SE
- Employees
- 160
- IPO date
- Jun 21, 2017
Bonesupport Holding has a wide economic moat
Bonesupport Holding AB possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysisContinue BOEUF Research
Decided on Bonesupport Holding? Get an email when BOEUF reaches the price you’d buy at. Free with an account.
Other Bonesupport Holding listings
What is the Intrinsic Value of one BOEUF stock?
The intrinsic value for
Bonesupport Holding AB (BOEUF) under the Base Case is 49.034 USD.
Is BOEUF stock undervalued or overvalued?
Compared with the current market price of 31.865 USD, the stock appears Undervalued by 35% .